BIO-RAD LABORATORIES, INC. Deferred Federal Income Tax Expense (Benefit)
BIO-RAD LABORATORIES, INC. (BIO) reported Deferred Federal Income Tax Expense (Benefit) of $182.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-02-13
- BIO-RAD LABORATORIES, INC. deferred federal income tax expense (benefit) for fiscal 2025 was $182.70M.
- BIO-RAD LABORATORIES, INC. deferred federal income tax expense (benefit) for fiscal 2024 was -$571.60M.
- BIO-RAD LABORATORIES, INC. deferred federal income tax expense (benefit) for fiscal 2023 was -$291.70M.
- BIO-RAD LABORATORIES, INC. deferred federal income tax expense (benefit) for fiscal 2022 was -$1.12B, a 214.01% decline from fiscal 2021.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $182.70M 10-K · filed 2026-02-13 | |
| 2024-12-31 | -$571.60M 10-K · filed 2026-02-13 | |
| 2023-12-31 | -$291.70M 10-K · filed 2026-02-13 | |
| 2022-12-31 | -$1.12B 10-K · filed 2025-02-14 | |
| 2021-12-31 | $983.50M 10-K · filed 2024-02-16 | $981.30M 10-K · filed 2022-02-11 |
| 2020-12-31 | $895.60M 10-K · filed 2023-02-17 | $893.50M 10-K · filed 2021-02-16 |
| 2019-12-31 | $409.70M 10-K · filed 2022-02-11 | |
| 2018-12-31 | $114.00M 10-K · filed 2021-02-16 | |
| 2017-12-31 | -$69.80M 10-K · filed 2020-03-02 | |
| 2016-12-31 | -$42.40M 10-K · filed 2019-04-01 | |
| 2015-12-31 | $2.00M 10-K · filed 2018-04-16 | -$200.00K 10-K · filed 2016-02-29 |
| 2014-12-31 | $1.50M 10-K · filed 2017-03-01 | |
| 2013-12-31 | $4.80M 10-K · filed 2016-02-29 | |
| 2012-12-31 | -$3.10M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $6.70M 10-K · filed 2014-03-18 | |
| 2010-12-31 | $5.90M 10-K · filed 2013-03-18 | |
| 2009-12-31 | -$2.50M 10-K · filed 2012-02-29 |